Canopy Biosciences Revenue and Competitors

Location

$4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Canopy Biosciences's estimated annual revenue is currently $2.6M per year.(i)
  • Canopy Biosciences's estimated revenue per employee is $77,500
  • Canopy Biosciences's total funding is $4M.

Employee Data

  • Canopy Biosciences has 33 Employees.(i)
  • Canopy Biosciences grew their employee count by -54% last year.

Canopy Biosciences's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Head Clinical DevelopmentReveal Email/Phone
3
Director OperationsReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
Digital Marketing ManagerReveal Email/Phone
7
R&D ManagerReveal Email/Phone
8
Manager R&D and OperationsReveal Email/Phone
9
ScientistReveal Email/Phone
10
Quality Management SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.4M5120%N/AN/A
#2
$1.1M70%N/AN/A
#3
$2.5M1633%N/AN/A
#4
$5M3214%N/AN/A
#5
$1.1M717%N/AN/A
#6
$6M393%N/AN/A
#7
$3.4M22-8%N/AN/A
#8
$0.3M40%N/AN/A
#9
$7.4M4850%N/AN/A
#10
$5.7M370%N/AN/A
Add Company

What Is Canopy Biosciences?

Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing key technologies in the fields of genetic engineering and personalized medicine. Founded in 2016, Canopy has offices and laboratories in St. Louis, MO.

keywords:N/A

$4M

Total Funding

33

Number of Employees

$2.6M

Revenue (est)

-54%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Canopy Biosciences News

2022-04-13 - Latest Bruker innovations for multiplexed spatial proteomics

Canopy Biosciences' CellScape is the latest generation ChipCytometry™ instrument, which enables high-plex spatial imaging and quantification...

2022-04-06 - Bruker Announces Key Innovations for Multiplexed Spatial ...

Canopy Biosciences' CellScape is the latest generation ChipCytometry TM instrument, which enables high-plex spatial imaging and...

2022-03-22 - Canopy Biosciences Launches Next-Generation ChipCytometry ...

Canopy Biosciences is headquartered in St. Louis, Missouri, with a CLIA site in California, and a site in Germany to serve researchers at...

2019-04-30 - Canopy Biosciences Acquires Zellkraftwerk

Canopy Biosciences, a St. Louis, MO-based provider of gene editing and gene expression products and services, acquired Zellkraftwerk GmbH, a Leipzig, Germany-based multiplex cytometry company. Concurrent with the acquisition, Canopy closed a strategic growth investment from Ampersand Capital Pa ...

2018-05-22 - Canopy Biosciences Closes $2.4M Series A Funding

Canopy Biosciences, a St. Louis-based life sciences company, closed a $2.4m Series A financing. BioGenerator, the investment arm of BioSTL, and Kingdom Capital co-led the round, which saw participation from The Missouri Technology Corporation (MTC), PinPoint Holdings, Greenleaf Fund, and Arch A ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M333%N/A
#2
$7.1M33-6%N/A
#3
$4.6M3327%N/A
#4
$7.1M3310%N/A
#5
$4M3327%N/A